|
1
|
Schlom J: Therapeutic cancer vaccines:
current status and moving forward. J Natl Cancer Inst. 104:599–613.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Drake CG: Prostate cancer as a model for
tumour immunotherapy. Nat Rev Immunol. 10:580–593. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Gruijl TD, van den Eertwegh AJ, Pinedo
HM and Scheper RJ: Whole-cell cancer vaccination: from autologous
to allogeneic tumor- and dendritic cell-based vaccines. Cancer
Immunol Immunother. 57:1569–1577. 2008.PubMed/NCBI
|
|
4
|
Yamada A, Sasada T, Noguchi M and Itoh K:
Next-generation peptide vaccines for advanced cancer. Cancer Sci.
104:15–21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sugimoto M, Watanabe M, Kaku H, Li SA,
Noguchi H, Ueki H, Sakaguchi M, Huh NH, Nasu Y and Kumon H:
Preclinical biodistribution and safety study of reduced expression
in immortalized cells/Dickkopf-3-encoding adenoviral vector for
prostate cancer gene therapy. Oncol Rep. 28:1645–1652. 2012.
|
|
6
|
Hirata T, Watanabe M, Kaku H, Kobayashi Y,
Yamada H, Sakaguchi M, Takei K, Huh NH, Nasu Y and Kumon H:
REIC/Dkk-3-encoding adenoviral vector as a potentially effective
therapeutic agent for bladder cancer. Int J Oncol. 41:559–564.
2012.PubMed/NCBI
|
|
7
|
Shirakawa T: Clinical trial design for
adenoviral gene therapy products. Drug News Perspect. 22:140–145.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lipinski KS, Pelech S, Mountain A, Irvine
AS, Kraaij R, Bangma CH, Mills KH and Todryk SM:
Nitroreductase-based therapy of prostate cancer, enhanced by
raising expression of heat shock protein 70, acts through increased
anti-tumour immunity. Cancer Immunol Immunother. 55:347–354. 2006.
View Article : Google Scholar
|
|
9
|
Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y
and Namba M: A REIC gene shows down-regulation in human
immortalized cells and human tumor-derived cell lines. Biochem
Biophys Res Commun. 268:20–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nozaki I, Tsuji T, Iijima O, Ohmura Y,
Andou A, Miyazaki M, Shimizu N and Namba M: Reduced expression of
REIC/Dkk-3 gene in non-small cell lung cancer. Int J Oncol.
19:117–121. 2001.PubMed/NCBI
|
|
11
|
Kurose K, Sakaguchi M, Nasu Y, Ebara S,
Kaku H, Kariyama R, Arao Y, Miyazaki M, Tsushima T, Namba M, Kumon
H and Huh NH: Decreased expression of REIC/Dkk-3 in human renal
clear cell carcinoma. J Urol. 171:1314–1318. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsieh SY, Hsieh PS, Chiu CT and Chen WY:
Dickkopf-3/REIC functions as a suppressor gene of tumor growth.
Oncogene. 23:9183–9189. 2004.PubMed/NCBI
|
|
13
|
Abarzua F, Sakaguchi M, Takaishi M, Nasu
Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H and Huh NH:
Adenovirus-mediated overexpression of REIC/Dkk-3 selectively
induces apoptosis in human prostate cancer cells through activation
of c-Jun-NH2-kinase. Cancer Res. 65:9617–9622. 2005. View Article : Google Scholar
|
|
14
|
Sato H, Suzuki H, Toyota M, Nojima M,
Maruyama R, Sasaki S, Takagi H, Sogabe Y, Sasaki Y, Idogawa M,
Sonoda T, et al: Frequent epigenetic inactivation of DICKKOPF
family genes in human gastrointestinal tumors. Carcinogenesis.
28:2459–2466. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang B, Du Z, Gao YT, Lou C, Zhang SG, Bai
T, Wang YJ and Song WQ: Methylation of Dickkopf-3 as a prognostic
factor in cirrhosis-related hepatocellular carcinoma. World J
Gastroenterol. 16:755–763. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Veeck J and Dahl E: Targeting the Wnt
pathway in cancer: the emerging role of Dickkopf-3. Biochim Biophys
Acta. 1825:18–28. 2012.PubMed/NCBI
|
|
17
|
Hayashi T, Asano H, Toyooka S, Tsukuda K,
Soh J, Shien T, Taira N, Maki Y, Tanaka N, Doihara H, Nasu Y, Huh
NH and Miyoshi S: DNA methylation status of REIC/Dkk-3 gene in
human malignancies. J Cancer Res Clin Oncol. 138:799–809. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanimoto R, Abarzua F, Sakaguchi M,
Takaishi M, Nasu Y, Kumon H and Huh NH: REIC/Dkk-3 as a potential
gene therapeutic agent against human testicular cancer. Int J Mol
Med. 19:363–368. 2007.PubMed/NCBI
|
|
19
|
Kashiwakura Y, Ochiai K, Watanabe M,
Abarzua F, Sakaguchi M, Takaoka M, Tanimoto R, Nasu Y, Huh NH and
Kumon H: Down-regulation of inhibition of differentiation-1 via
activation of activating transcription factor 3 and Smad regulates
REIC/Dickkopf-3-induced apoptosis. Cancer Res. 68:8333–8341. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kawasaki K, Watanabe M, Sakaguchi M,
Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH,
Kumon H and Date H: REIC/Dkk-3 overexpression downregulates
P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces
apoptosis in breast cancer. Cancer Gene Ther. 16:65–72. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sakaguchi M, Huh NH and Namba M: A novel
tumor suppressor, REIC/Dkk-3 gene identified by our in vitro
transformation model of normal human fibroblasts works as a potent
therapeutic anti-tumor agent. Adv Exp Med Biol. 720:209–215. 2011.
View Article : Google Scholar
|
|
22
|
Zhang K, Watanabe M, Kashiwakura Y, Li SA,
Edamura K, Huang P, Yamaguchi K, Nasu Y, Kobayashi Y, Sakaguchi M,
Ochiai K, et al: Expression pattern of REIC/Dkk-3 in various cell
types and the implications of the soluble form in prostatic acinar
development. Int J Oncol. 37:1495–1501. 2010.PubMed/NCBI
|
|
23
|
Kobayashi K, Ouchida M, Tsuji T, Hanafusa
H, Miyazaki M, Namba M, Shimizu N and Shimizu K: Reduced expression
of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor
cells. Gene. 282:151–158. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pinho S and Niehrs C: Dkk3 is required for
TGF-beta signaling during Xenopus mesoderm induction.
Differentiation. 75:957–967. 2007.PubMed/NCBI
|
|
25
|
Onai T, Takai A, Setiamarga DH and Holland
LZ: Essential role of Dkk3 for head formation by inhibiting
Wnt/β-catenin and Nodal/Vg1 signaling pathways in the basal
chordate amphioxus. Evol Dev. 14:338–350. 2012.PubMed/NCBI
|
|
26
|
Kawano Y, Kitaoka M, Hamada Y, Walker MM,
Waxman J and Kypta RM: Regulation of prostate cell growth and
morphogenesis by Dickkopf-3. Oncogene. 25:6528–6537. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Romero D, Kawano Y, Bengoa N, Walker MM,
Maltry N, Niehrs C, Waxman J and Kypta R: Downregulation of
Dickkopf-3 disrupts prostate acinar morphogenesis through
TGF-β/Smad signaling. J Cell Sci. 126:1858–1867. 2013.PubMed/NCBI
|
|
28
|
Karamariti E, Margariti A, Winker B, Wang
X, Hong X, Baban D, Ragoussis J, Huang Y, Han JD, Wong MM, Sag CM,
et al: Smooth muscle cells differentiated from reprogrammed
embryonic lung fibroblasts through DKK3 signalling are potent for
tissue engineering of vascular grafts. Circ Res. 112:1433–1443.
2013. View Article : Google Scholar
|
|
29
|
Nakamura RE and Hackam AS: Analysis of
Dickkopf3 interactions with Wnt signaling receptors. Growth
Factors. 28:232–242. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park
J, Chae M, Zhang W and Lee JH: Dkk3, downregulated in cervical
cancer, functions as a negative regulator of beta-catenin. Int J
Cancer. 124:287–297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ochiai K, Watanabe M, Ueki H, Huang P,
Fujii Y, Nasu Y, Noguchi H, Hirata T, Sakaguchi M, Huh NH,
Kashiwakura Y, et al: Tumor suppressor REIC/Dkk-3 interacts with
the dynein light chain, Tctex-1. Biochem Biophys Res Commun.
412:391–395. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin CL, Wang JY, Ko JY, Huang YT, Kuo YH
and Wang FS: Dickkopf-1 promotes hyperglycemia-induced accumulation
of mesangial matrix and renal dysfunction. J Am Soc Nephrol.
21:124–135. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Watanabe M, Kashiwakura Y, Huang P, Ochiai
K, Futami J, Li SA, Takaoka M, Nasu Y, Sakaguchi M, Huh NH and
Kumon H: Immunological aspects of REIC/Dkk-3 in monocyte
differentiation and tumor regression. Int J Oncol. 34:657–663.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cunningham NS, Paralkar V and Reddi AH:
Osteogenin and recombinant bone morphogenetic protein 2B are
chemotactic for human monocytes and stimulate transforming growth
factor beta 1 mRNA expression. Proc Natl Acad Sci USA.
89:11740–11744. 1992. View Article : Google Scholar
|
|
35
|
Manicassamy S, Reizis B, Ravindran R,
Nakaya H, Salazar-Gonzalez RM, Wang YC and Pulendran B: Activation
of beta-catenin in dendritic cells regulates immunity versus
tolerance in the intestine. Science. 329:849–853. 2010. View Article : Google Scholar
|
|
36
|
Valencia J, Hernández-López C, Martínez
VG, Hidalgo L, Zapata AG, Vicente Á, Varas A and Sacedón R: Wnt5a
skews dendritic cell differentiation to an unconventional phenotype
with tolerogenic features. J Immunol. 187:4129–4139. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Van den Bossche J, Malissen B, Mantovani
A, De Baetselier P and Van Ginderachter JA: Regulation and function
of the E-cadherin/catenin complex in cells of the
monocyte-macrophage lineage and DCs. Blood. 119:1623–1633.
2012.PubMed/NCBI
|
|
38
|
Niwa H, Yamamura K and Miyazaki J:
Efficient selection for high-expression transfectants with a novel
eukaryotic vector. Gene. 108:193–199. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Araki K, Araki M, Miyazaki J and Vassalli
P: Site-specific recombination of a transgene in fertilized eggs by
transient expression of Cre recombinase. Proc Natl Acad Sci USA.
92:160–164. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sakaguchi M, Kataoka K, Abarzua F,
Tanimoto R, Watanabe M, Murata H, Than SS, Kurose K, Kashiwakura Y,
Ochiai K, Nasu Y, et al: Overexpression of REIC/Dkk-3 in normal
fibroblasts suppresses tumor growth via induction of interleukin-7.
J Biol Chem. 284:14236–14244. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mizobuchi Y, Matsuzaki K, Kuwayama K,
Kitazato K, Mure H, Kageji T and Nagahiro S: REIC/Dkk-3 induces
cell death in human malignant glioma. Neuro Oncol. 10:244–253.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Edamura K, Nasu Y, Takaishi M, Kobayashi
T, Abarzua F, Sakaguchi M, Kashiwakura Y, Ebara S, Saika T,
Watanabe M, Huh NH and Kumon H: Adenovirus-mediated REIC/Dkk-3 gene
transfer inhibits tumor growth and metastasis in an orthotopic
prostate cancer model. Cancer Gene Ther. 14:765–772. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Than SS, Kataoka K, Sakaguchi M, Murata H,
Abarzua F, Taketa C, Du G, Yashiro M, Yanagihara K, Nasu Y, Kumon H
and Huh NH: Intraperitoneal administration of an adenovirus vector
carrying REIC/Dkk-3 suppresses peritoneal dissemination of
scirrhous gastric carcinoma. Oncol Rep. 25:989–995. 2011.
|
|
44
|
Naume B and Espevik T: Effects of IL-7 and
IL-2 on highly enriched CD56+ natural killer cells. A
comparative study. J Immunol. 147:2208–2214. 1991.PubMed/NCBI
|
